Nicholas O. Bowlin

Mutations in the Pseudomonas aeruginosa Needle Protein Gene <i>pscF</i> Confer Resistance to Phenoxyacetamide Inhibitors of the Type III Secretion System

Nicholas O. Bowlin, John D. Williams, Claire A. Knoten et al. · Antimicrobial Agents and Chemotherapy · 2014 · 65 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +13

Impact of Type III Secretion Effectors and of Phenoxyacetamide Inhibitors of Type III Secretion on Abscess Formation in a Mouse Model of Pseudomonas aeruginosa Infection

Bryan J. Berube, Katherine R. Murphy, Matthew C. Torhan et al. · Antimicrobial Agents and Chemotherapy · 2017 · 54 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +16

Synthesis and structure–activity relationships of novel phenoxyacetamide inhibitors of the Pseudomonas aeruginosa type III secretion system (T3SS)

John D. Williams, Matthew C. Torhan, Venugopal Rao Neelagiri et al. · Bioorganic & Medicinal Chemistry · 2015 · 42 citations · Full text

Pharmacy, Pharmacology, Drug Design +11

Discovery of Bacterial Fatty Acid Synthase Type II Inhibitors Using a Novel Cellular Bioluminescent Reporter Assay

Joselynn Wallace, Nicholas O. Bowlin, Debra M. Mills et al. · Antimicrobial Agents and Chemotherapy · 2015 · 23 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17